Lorenz Kocheise

6PUBLICATIONS
43CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 27, 2023
Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study.

Vincent Joerg, Bernhard Scheiner, Antonio D Alessio

|Jul 17, 2021
OAS1/RNase L executes RIG-I ligand-dependent tumor cell apoptosis.

Daniel F R Boehmer, Simone Formisano, Carina C de Oliveira Mann

Pageof 1